Common functional variants of APOA5 and GCKR accumulate gradually in association with triglyceride increase in metabolic syndrome patients

Molecular Biology Reports

Volumn 39, Issue 2, 2012, Pages 1949-1955

  Hadarits, Ferenc ^a   Kisfali, Péter ^b   Mohás, Marton ^c   Maász, Anita ^b   Duga, Balázs ^b   Janicsek, Ingrid ^b   Wittmann, István ^c   Melegh, Béla ^b  

^a Markusovszky Teaching Hospital   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

Author keywords

APOA5; GCKR; Metabolic syndrome; Triglycerides

Indexed keywords

APOLIPOPROTEIN A5; TRIACYLGLYCEROL; APOA5 PROTEIN, HUMAN; APOLIPOPROTEIN A; GCKR PROTEIN, HUMAN; PRIMER DNA; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; APOA5 GENE; ARTICLE; CONTROLLED STUDY; GCKR GENE; GENE; GENE FREQUENCY; GENE FUNCTION; GENETIC VARIABILITY; HAPLOTYPE; HOMOZYGOTE; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MOUSE; NONHUMAN; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; GENETICS; METABOLISM; NONPARAMETRIC TEST; PREVALENCE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOLIPOPROTEINS A; DNA PRIMERS; GENE FREQUENCY; HAPLOTYPES; HUMANS; METABOLIC SYNDROME X; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; STATISTICS, NONPARAMETRIC; TRIGLYCERIDES;

EID: 84860323241     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-0942-8     Document Type: Article

References (32)

1. Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart et al (2001) An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294:169-173 (Pubitemid 32952971)
2. Kao JT, Wen HC, Chien KL, Hsu HC, Lin SW (2003) A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia. Hum Mol Genet 12:2533-2539
3. Dallongeville J, Cottel D, Montaye M, Codron V, Amouyel P, Helbecque N (2006) Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men. Int J Cardiol 106:152-156 (Pubitemid 41728931)
4. Priore OC, Tarugi P, Calandra S, Pisciotta L, Bellocchio A, Bertolini S et al (2006) A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia. Atherosclerosis 188:215-217 (Pubitemid 44142548)
5. Szalai C, Keszei M, Duba J, Prohaszka Z, Kozma GT, Csaszar A et al (2004) Polymorphism in the promoter region of the apoli-poprotein A5 gene is associated with an increased susceptibility for coronary artery disease. Atherosclerosis 173:109-114 (Pubitemid 38224202)
6. Hyun YJ, Jang Y, Chae JS, Kim JY, Paik JK, Kim SY et al (2009) Association of apolipoprotein A5 concentration with serum insulin and triglyceride levels and coronary artery disease in Korean men. Atherosclerosis 205:568-573
7. Havasi V, Szolnoki Z, Talian G, Bene J, Komlosi K, Maasz A et al (2006) Apolipoprotein A5 gene promoter region T-1131C polymorphism associates with elevated circulating triglyceride levels and confers susceptibility for development of ischemic stroke. J Mol Neurosci 29:177-183 (Pubitemid 44352541)
8. Maasz A, Kisfali P, Szolnoki Z, Hadarits F, Melegh B (2008) Apolipoprotein A5 gene C56G variant confers risk for the development of large-vessel associated ischemic stroke. J Neurol 255:649-654
9. Merkel M, Heeren J (2005) Give me A5 for lipoprotein hydrolysis. J Clin Invest 115:2694-2696
10. Marcais C, Verges B, Charriere S, Pruneta V, Merlin M, Billon S et al (2005) Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment. J Clin Invest 115:2862-2869 (Pubitemid 41434413)
11. Wang J, Ban MR, Kennedy BA, Anand S, Yusuf S, Huff MW et al (2008) APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia. Nat Clin Pract Cardiovasc Med 5:730-737
12. Komurcu-Bayrak E, Onat A, Poda M, Humphries SE, Palmen J, Guclu F et al (2008) Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T[C and c.56C[G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults. Clin Chem Lab Med 46:778-784 (Pubitemid 351821636)
13. Kisfali P, Mohas M, Maasz A, Polgar N, Hadarits F, Marko L et al (2010) Haplotype analysis of the apolipoprotein A5 gene in patients with the metabolic syndrome. Nutr Metab Cardiovasc Dis 20:505-511
14. Hayward BE, Dunlop N, Intody S, Leek JP, Markham AF, Warner JP, Bonthron DT (1998) Organization of the human glucokinase regulator gene GCKR. Genomics 49:137-142 (Pubitemid 28194447)
15. Warner JP, Leek JP, Intody S, Markham AF, Bonthron DT (1995) Human glucokinase regulatory protein (GCKR): cDNA and genomic cloning, complete primary structure, and chromosomal localization. Mamm Genome 6:532-536
16. Farrelly D, Brown KS, Tieman A, Ren J, Lira SA, Hagan D et al (1999) Mice mutant for glucokinase regulatory protein exhibit decreased liver glucokinase: a sequestration mechanism in metabolic regulation. Proc Natl Acad Sci USA 96:14511-14516 (Pubitemid 30000681)
17. Grimsby J, Coffey JW, Dvorozniak MT, Magram J, Li G, Mats-chinsky FM, Shiota C et al (2000) Characterization of glucokinase regulatory protein-deficient mice. J Biol Chem 275:7826-7831 (Pubitemid 30159689)
18. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU et al (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42:105-116
19. Beer NL, Tribble ND, McCulloch LJ, Roos C, Johnson PR, Orho-Melander M, Gloyn AL (2009) The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver. Hum Mol Genet 18:4081-4088
20. Qi Q, Wu Y, Li H, Loos RJ, Hu FB, Sun L et al (2009) Association of GCKR rs780094, alone or in combination with GCK rs1799884, with type 2 diabetes and related traits in a Han Chinese population. Diabetologia 52:834-843
21. Hadarits F, Kisfali P, Mohas M, Maasz A, Sumegi K, Szabo M et al (2011) Stepwise positive association between APOA5 minor allele frequencies and increasing plasma triglyceride quartiles in random patients with hypertriglyceridemia of unclarified origin. Pathol Oncol Res 17:39-44
22. Jaromi L, Csongei V, Polgar N, Szolnoki Z, Maasz A, Horvato-vich K et al (2010) Functional variants of glucokinase regulatory protein and apolipoprotein A5 genes in ischemic stroke. J Mol Neurosci 41:121-128
23. Liu ZK, Hu M, Baum L, Thomas GN, Tomlinson B (2010) Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese. Atherosclerosis 208:427-432
24. Delgado-Lista J, Perez-Jimenez F, Ruano J, Perez-Martinez P, Fuentes F, Criado-Garcia J et al (2010) Effects of variations in the APOA1/C3/A4/A5 gene cluster on different parameters of postprandial lipid metabolism in healthy young men. J Lipid Res 51:63-73
25. Hsu LA, Ko YL, Chang CJ, Teng MS, Wu S, Hu CF (2008) Apolipoprotein A5 gene -1131T/C polymorphism is associated with the risk of metabolic syndrome in ethnic Chinese in Taiwan. Clin Chem Lab Med 46:1714-1719
26. Johansen CT, Wang J, Lanktree MB, Cao H, McIntyre AD, Ban MR et al (2010) Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat Genet 42:684-687
27. Kisfali P, Mohas M, Maasz A, Hadarits F, Marko L, Horvatovich K et al (2008) Apolipoprotein A5 IVS3?476A allelic variant associates with increased triglyceride levels and confers risk for development of metabolic syndrome in Hungarians. Circ J 72:40-43 (Pubitemid 351413324)
28. Heredia VV, Carlson TJ, Garcia E, Sun S (2006) Biochemical basis of glucokinase activation and the regulation by glucokinase regulatory protein in naturally occurring mutations. J Biol Chem 281:40201-40207 (Pubitemid 46041825)
29. Vaxillaire M, Cavalcanti-Proenca C, Dechaume A, Tichet J, Marre M, Balkau B, Froguel P (2008) The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population. Diabetes 57:2253-2257
30. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H et al (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316:1331-1336 (Pubitemid 46871653)
31. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R et al (2008) Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40:161-169 (Pubitemid 351171403)
32. Hiskett EK, Suwitheechon OU, Lindbloom-Hawley S, Boyle DL, Schermerhorn T (2009) Lack of glucokinase regulatory protein expression may contribute to low glucokinase activity in feline liver. Vet Res Commun 33:227-240